Corteva (NYSE:CTVA) Stock Price Expected to Rise, BNP Paribas Exane Analyst Says

Corteva (NYSE:CTVA) had its price target increased by equities research analysts at BNP Paribas Exane from $72.00 to $74.00 in a report issued on Monday,MarketScreener reports. BNP Paribas Exane’s price target would suggest a potential downside of 3.50% from the company’s previous close.

Several other analysts have also commented on CTVA. Bank of America lifted their price objective on shares of Corteva from $80.00 to $82.00 and gave the stock a “buy” rating in a research report on Thursday, January 8th. JPMorgan Chase & Co. downgraded shares of Corteva from an “overweight” rating to a “neutral” rating and increased their target price for the company from $75.00 to $77.00 in a research report on Thursday, February 5th. Wolfe Research raised their price target on shares of Corteva from $81.00 to $86.00 and gave the stock an “outperform” rating in a research note on Thursday, February 5th. Rothschild & Co Redburn dropped their price objective on Corteva from $71.00 to $65.00 and set a “neutral” rating on the stock in a research note on Tuesday, November 11th. Finally, The Goldman Sachs Group reissued a “buy” rating and set a $88.00 price objective on shares of Corteva in a report on Thursday, February 5th. One research analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $82.90.

Corteva Stock Down 0.4%

Corteva stock traded down $0.28 during midday trading on Monday, hitting $76.68. 188,086 shares of the stock were exchanged, compared to its average volume of 4,035,306. The business’s 50-day moving average price is $73.00 and its 200-day moving average price is $69.00. The company has a quick ratio of 0.96, a current ratio of 1.43 and a debt-to-equity ratio of 0.07. Corteva has a 52-week low of $53.40 and a 52-week high of $80.90. The stock has a market capitalization of $51.57 billion, a price-to-earnings ratio of 48.53, a price-to-earnings-growth ratio of 2.63 and a beta of 0.72.

Corteva (NYSE:CTVA) last announced its quarterly earnings data on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.22. The firm had revenue of $3.91 billion during the quarter, compared to the consensus estimate of $4.23 billion. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The business’s revenue for the quarter was down 1.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.32 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, research analysts expect that Corteva will post 2.96 EPS for the current fiscal year.

Insider Transactions at Corteva

In other Corteva news, insider Brian Titus sold 8,311 shares of the business’s stock in a transaction on Friday, February 20th. The shares were sold at an average price of $76.55, for a total transaction of $636,207.05. Following the sale, the insider owned 8,090 shares of the company’s stock, valued at $619,289.50. The trade was a 50.67% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.15% of the stock is owned by insiders.

Institutional Trading of Corteva

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. grew its holdings in Corteva by 0.4% during the 4th quarter. Vanguard Group Inc. now owns 80,536,951 shares of the company’s stock valued at $5,398,392,000 after buying an additional 317,538 shares in the last quarter. State Street Corp boosted its position in shares of Corteva by 3.7% in the fourth quarter. State Street Corp now owns 36,570,876 shares of the company’s stock valued at $2,451,346,000 after acquiring an additional 1,290,071 shares during the period. Franklin Resources Inc. grew its stake in Corteva by 4.3% during the fourth quarter. Franklin Resources Inc. now owns 19,537,500 shares of the company’s stock valued at $1,309,599,000 after acquiring an additional 805,873 shares in the last quarter. Geode Capital Management LLC increased its holdings in Corteva by 1.4% during the 2nd quarter. Geode Capital Management LLC now owns 18,047,263 shares of the company’s stock worth $1,339,651,000 after acquiring an additional 251,693 shares during the period. Finally, Harris Associates L P increased its holdings in Corteva by 168.1% during the 4th quarter. Harris Associates L P now owns 17,026,221 shares of the company’s stock worth $1,141,268,000 after acquiring an additional 10,675,052 shares during the period. 81.54% of the stock is currently owned by institutional investors.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.